Annotation Detail for PRICKLE2

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04310 | Wnt signaling pathway |
Desease Name |
---|
METABOLIC |
folate pathway vitamin levels |
Desease Name |
---|
Folate pathway vitamin levels |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PRICKLE2 mRNA | decreases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of PRICKLE2 mRNA | decreases expression | 16002434
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of PRICKLE2 mRNA | decreases expression | 20713471
|
D010634 |
Phenobarbital |
Phenobarbital affects the methylation of PRICKLE2 promoter | affects methylation | 19482888
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
4.07 | 6195326 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
3.70 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
4.60 | 17620307 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.66 | 11922910 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.50 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.50 | 17474063 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
4.29 | 10545420 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
1.95 | 20007298 1701930 17173139 20935162 6705139 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.71 | 11237771 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.73 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
7.73 | 16192471 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.81 | 4080065 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.21 | 19486331 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.47 | 1851702 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.44 | 15138306 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.67 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.59 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
3.06 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.91 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.81 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.65 | 3659116 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.28 | 19224547 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.57 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.70 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.85 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.05 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
4.04 | 16109766 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.21 | 10903974 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.54 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.08 | 12371664 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
3.08 | 21047994 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
2.24 | 19363144 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
2.42 | 15975961 19812893 8742319 21047994 19482888 19073162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
6.99 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
6.99 | 18308698 17172636 6150874 1399818 2563599 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
2.41 | 15390079 16271038 7750092 20512841 16337739 10545420 20970405 11893704 1399818 17909032 9230183 6695378 21163286 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.51 | 16801185 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
5.11 | 17484760 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.65 | 18481113 19348381 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
5.00 | 17016548 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.60 | 16965848 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
10.22 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
10.22 | 2563599 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.41 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.48 | 16644109 16289102 15754350 12479363 18247401 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
5.22 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.33 | 16882103 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.95 | 3137016 11442880 16876388 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.45 | 6407741 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.36 | 1399818 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.71 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.16 | 17120751 |
Pathway ID |
Pathway Name |
---|
KEGG:04310 |
Wnt signaling pathway |